SHORT-TERM EFFICACY AND SAFETY OF HIGH-INTENSITY STATIN THERAPY IN PATIENTS WITH VERY HIGH CARDIOVASCULAR RISK ArticleVorobyeva M.M., Doronina A., Lobzhanidze T., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. 17. 2015. P.. 87-87
VISIT-TO-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS ADVERSE OUTCOMES IN STABLE HEART FAILURE WITH REDUCED EJECTION FRACTION ArticleTroitskaya E.E., Kotovskaya Y.V., Babaeva L.A., Kobalava Z.D.European Journal of Heart Failure. Vol. 17. 2015. P.. 164-165